The improvement of recombinant antibody production in Chinese Hamster Ovary (CHO-K1) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various strategies are employed, including molecular engineering of the host cells and optimization of culture conditions. Additionally, implementation of advanced bioreactors can s